Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.47 |
| ▸ | SIRT1 | Q96EB6 | 7/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | PTPRC | P08575 | 2/20 | 0.45 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.45 |
| ▸ | SIRT2 | Q8IXJ6 | 4/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.43 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.43 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.43 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6421594 | 0.99 | SIRT1 (0.46) | HDAC8SIRT1L3MBTL1PTPRCSIRT2 | |
| SCHEMBL6416347 | 0.92 | GAA (0.53) | L3MBTL1PTPRCPTPN13GAA | |
| SCHEMBL6419374 | 0.84 | HDAC8 (0.49) | HDAC8L3MBTL1PTPRCPTPN13GAA | |
| SCHEMBL6421599 | 0.83 | GAA (0.48) | HDAC8L3MBTL1PTPRCPTPN13GAA | |
| SCHEMBL1577613 | 0.79 | CYP1A2 (0.59) | HDAC8L3MBTL1PTPRCPTPN13GAA | |
| SCHEMBL31635262 | 0.78 | L3MBTL1 (0.69) | HDAC8L3MBTL1PTPRCPTPN13GAA | |
| SCHEMBL2834485 | 0.78 | HDAC8 (0.58) | HDAC8L3MBTL1PTPRCPTPN13GAA | |
| SCHEMBL2598319 | 0.77 | HDAC8 (0.53) | HDAC8L3MBTL1PTPRCPTPN13HDAC3 | |
| SCHEMBL6421565 | 0.77 | PTPN1 (0.58) | L3MBTL1GAA | |
| SCHEMBL2836609 | 0.77 | TDP1 (0.56) | HDAC8L3MBTL1PTPRCPTPN13GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050043388-A1 | Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. | 2005-02-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050043388-A1 | Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) | PTPRO, PTPRE, PTPRZ1 | HDAC8 3154/4885SIRT1 2649/4885L3MBTL1 4356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.